GORE Septal Occluder
Total Payments
$150,956
Transactions
61
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $150,956 | 61 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $150,956 | 61 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| GORE Septal Occluder Clinical Study: A Study to evaluate safety and efficacy in the treatment of transcatheter closure of ostium secundum atrial septal defects (ASDs) | W. L. Gore & Associates, Inc. | $150,956 | 0 |
Top Doctors Receiving Payments for GORE Septal Occluder
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | New York, NY | $150,956 | 61 |
Ad
Manufacturing Companies
- W. L. Gore & Associates, Inc. $150,956
Product Information
- Type Device
- Total Payments $150,956
- Total Doctors 0
- Transactions 61
About GORE Septal Occluder
GORE Septal Occluder is a device associated with $150,956 in payments to 0 healthcare providers, recorded across 61 transactions in the CMS Open Payments database. The primary manufacturer is W. L. Gore & Associates, Inc..
Payment data is available from 2017 to 2017. In 2017, $150,956 was paid across 61 transactions to 0 doctors.
The most common payment nature for GORE Septal Occluder is "Unspecified" ($150,956, 100.0% of total).
GORE Septal Occluder is associated with 1 research study, including "GORE Septal Occluder Clinical Study: A Study to evaluate safety and efficacy in the treatment of transcatheter closure of ostium secundum atrial septal defects (ASDs)" ($150,956).